Recent Cancer Treatment Research for November 2024
Metastatic triple-negative breast cancer (mTNBC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Women's Health, Oncology/Hematology
| Non-Muscle Invasive Bladder Cancer (NMIBC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Relapsed/Refractory Multiple Myeloma (RRMM) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Bowen's Disease - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery
| Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Natural Killer (NK)-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Marginal Zone Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Metastatic Merkel Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology
| Osteosarcoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
| Acute Myeloid Leukemia (AML) - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Multiple Myeloma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
| Prostate cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
| Synovial sarcoma (SS) - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
| Peripheral T cell Lymphoma - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Cancer Cachexia (CC)– Epidemiology Forecast—2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast–2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Castrate-Resistant Prostate Cancer (CRPC)- Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
| Metastatic Colorectal Cancer Epidemiology Forecast to 2032
Topics: Cancer Treatment, Oncology/Hematology
| ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology
| Metastatic triple-negative breast cancer (mTNBC)
- Epidemiology Forecast - 2032
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Oncolytic Virus Cancer Therapy - Pipeline Insight, 2022
Topics: Cancer Treatment, Oncology/Hematology
| NK Cell therapies - Pipeline Insight, 2022
Topics: Cancer Treatment, Drug Discovery
| Lymphoedema - Market Insights, Competitive Landscape and Market Forecast–2026
Topics: Pain, Cancer Treatment, Drug Discovery
| Radiologic Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026
Topics: Cancer Treatment, Oncology/Hematology
| 2022-2026 Europe Cancer Diagnostics Market Opportunities for Major Tumor Markers for Major Tumor Markers: A 38-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipelin
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Europe
| 2022-2026 Middle East Cancer Diagnostics Market Opportunities for Major Tumor Markers: An 11-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opport
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Middle East
| 2022-2026 North America Cancer Diagnostics Market Opportunities for Major Tumor Markers: US, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportun
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
| 2022-2026 Asia-Pacific Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 18 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Asia, Oceania
| 2022-2026 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 38 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Europe
| 2022-2026 North America Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - USA, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, T
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
| 2022-2026 Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - USA, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and O
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Japan, United States, Europe, Global
| 2022-2026 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - France, German, Italy, Spain, UK - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprot
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| 2022-2026 France Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Te
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: France
| 2022-2026 Germany Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest T
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Germany
| 2022-2026 Italy Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Italy
| 2022-2026 Australia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Australia
| 2022-2026 China Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: China
| 2022-2026 Russia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Te
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays, Oncology/Hematology
Regions: Russia
| Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis
Topics: Cancer Treatment, COVID-19/Coronavirus, Respiratory/Pulmonary, Oncology/Hematology
Regions: Global
| Nasal Cannula Market, by Product Type (Curved prong cannula, Flared prong cannula, Straight prong cannula, Curved and flared prong cannula) by Material (Plastic, Silicon ) by Application (Asthma, Lung cancer, Chronic bronchitis, Pulmonary embolism, COPD,
Topics: Asthma, Cancer Treatment, Hospitals & Clinics, Long-Term Care, Equipment & Supplies, Respiratory Devices, Respiratory/Pulmonary
Regions: Asia, Europe, Middle East, Oceania
| Thymus Cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Thyroid Cancer - Epidemiology Forecast to 2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Peripheral T-Cell Lymphoma (PTCL) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Cancer Treatment, COVID-19/Coronavirus, Endoscopy, Computed Tomography (CT), Oncology/Hematology
| Gallbladder Cancer - Global Clinical Trials Review, H2, 2021
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
Regions: Global
| Global Platinum Based Cancer Drug Market - 2021-2028
Topics: Cancer Treatment, Platinum, Oncology/Hematology
Regions: Global
| 2022-2026 North America Immunodiagnostic Analyzers and Reagents - USA, Canada, Mexico - Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special
Topics: Instrumentation & Equipment, Cancer Treatment, Immunoassays, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
| 2022-2026 Canada Immunodiagnostic Analyzers and Reagents - Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Tec
Topics: Instrumentation & Equipment, Cancer Treatment, Immunoassays, Oncology/Hematology
Regions: Canada
| Platinum-Resistant Relapsed Ovarian Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Women's Health, Oncology/Hematology, Obstetrics/Gynecology, Reproductive Health
| Injectable Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Biologics, Cancer Treatment, COVID-19/Coronavirus, Needles, Syringes, IV Access, Cardiovascular, Cancer Vaccines, Pandemic Vaccines
|
Prev | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
